241 related articles for article (PubMed ID: 9001420)
21. Frequent inactivation of the cyclin-dependent kinase inhibitor p18 by homozygous deletion in multiple myeloma cell lines: ectopic p18 expression inhibits growth and induces apoptosis.
Kulkarni MS; Daggett JL; Bender TP; Kuehl WM; Bergsagel PL; Williams ME
Leukemia; 2002 Jan; 16(1):127-34. PubMed ID: 11840272
[TBL] [Abstract][Full Text] [Related]
22. Expression of cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of the BCL1/cyclin D1 gene.
Swerdlow SH; Yang WI; Zukerberg LR; Harris NL; Arnold A; Williams ME
Hum Pathol; 1995 Sep; 26(9):999-1004. PubMed ID: 7545645
[TBL] [Abstract][Full Text] [Related]
23. Cyclin D1 overexpression in malignant lymphomas.
Nakamura S; Yatabe Y; Seto M
Pathol Int; 1997 Jul; 47(7):421-9. PubMed ID: 9234379
[TBL] [Abstract][Full Text] [Related]
24. Deletion and differential expression of p16INK4a in mouse lung tumors.
Belinsky SA; Swafford DS; Middleton SK; Kennedy CH; Tesfaigzi J
Carcinogenesis; 1997 Jan; 18(1):115-20. PubMed ID: 9054597
[TBL] [Abstract][Full Text] [Related]
25. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
Phelps DE; Xiong Y
Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
[TBL] [Abstract][Full Text] [Related]
26. Chemical transformation of mouse liver cells results in altered cyclin D-CDK protein complexes.
Gonzales AJ; Goldsworthy TL; Fox TR
Carcinogenesis; 1998 Jun; 19(6):1093-102. PubMed ID: 9667749
[TBL] [Abstract][Full Text] [Related]
27. bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma.
Ott MM; Helbing A; Ott G; Bartek J; Fischer L; Dürr A; Kreipe H; Müller-Hermelink HK
J Pathol; 1996 Jul; 179(3):238-42. PubMed ID: 8774476
[TBL] [Abstract][Full Text] [Related]
28. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia.
Guo SX; Taki T; Ohnishi H; Piao HY; Tabuchi K; Bessho F; Hanada R; Yanagisawa M; Hayashi Y
Leuk Res; 2000 Jan; 24(1):39-46. PubMed ID: 10634644
[TBL] [Abstract][Full Text] [Related]
29. Implication of cyclin D1 in malignant lymphoma.
Callanan M; Leroux D; Magaud JP; Rimokh R
Crit Rev Oncog; 1996; 7(3-4):191-203. PubMed ID: 9258602
[TBL] [Abstract][Full Text] [Related]
30. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
[TBL] [Abstract][Full Text] [Related]
31. Biochemical characterization of p16INK4- and p18-containing complexes in human cell lines.
Ragione FD; Russo GL; Oliva A; Mercurio C; Mastropietro S; Pietra VD; Zappia V
J Biol Chem; 1996 Jul; 271(27):15942-9. PubMed ID: 8663131
[TBL] [Abstract][Full Text] [Related]
32. Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line.
Hochhauser D; Schnieders B; Ercikan-Abali E; Gorlick R; Muise-Helmericks R; Li WW; Fan J; Banerjee D; Bertino JR
J Natl Cancer Inst; 1996 Sep; 88(18):1269-75. PubMed ID: 8797766
[TBL] [Abstract][Full Text] [Related]
33. Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma.
de Boer CJ; Schuuring E; Dreef E; Peters G; Bartek J; Kluin PM; van Krieken JH
Blood; 1995 Oct; 86(7):2715-23. PubMed ID: 7670110
[TBL] [Abstract][Full Text] [Related]
34. Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A.
Møller MB; Kania PW; Ino Y; Gerdes AM; Nielsen O; Louis DN; Skjødt K; Pedersen NT
Leukemia; 2000 May; 14(5):898-904. PubMed ID: 10803523
[TBL] [Abstract][Full Text] [Related]
35. Loss of cyclin-dependent kinase inhibitor genes and chromosome 9 karyotypic abnormalities in human bladder cancer cell lines.
Southgate J; Proffitt J; Roberts P; Smith B; Selby P
Br J Cancer; 1995 Nov; 72(5):1214-8. PubMed ID: 7577470
[TBL] [Abstract][Full Text] [Related]
36. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
37. BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation.
Lukas J; Jadayel D; Bartkova J; Nacheva E; Dyer MJ; Strauss M; Bartek J
Oncogene; 1994 Aug; 9(8):2159-67. PubMed ID: 8036001
[TBL] [Abstract][Full Text] [Related]
38. A novel pre-B acute lymphoblastic leukemia cell line with chromosomal translocation between p16(INK4A)/p15(INK4B) tumor suppressor and immunoglobulin heavy chain genes: TGFbeta/IL-7 inhibitory signaling mechanism.
Urashima M; Hoshi Y; Sugimoto Y; Kaihara C; Matsuzaki M; Chauhan D; Ogata A; Teoh G; DeCaprio JA; Anderson KC
Leukemia; 1996 Oct; 10(10):1576-83. PubMed ID: 8847892
[TBL] [Abstract][Full Text] [Related]
39. Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.
Maelandsmo GM; Flørenes VA; Hovig E; Oyjord T; Engebraaten O; Holm R; Børresen AL; Fodstad O
Br J Cancer; 1996 Apr; 73(8):909-16. PubMed ID: 8611425
[TBL] [Abstract][Full Text] [Related]
40. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1.
Schulze A; Zerfass K; Spitkovsky D; Henglein B; Jansen-Dürr P
Oncogene; 1994 Dec; 9(12):3475-82. PubMed ID: 7970707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]